Harwood Capital

Harwood Capital is a London-based investment management group specializing in small-cap companies, with a strategic focus on the healthcare and life sciences sectors. Founded in 2011 by Christopher Mills following the sale of J O Hambro Capital Management, the firm manages a diverse range of listed investment trusts and private equity funds, most notably the North Atlantic Smaller Companies Investment Trust (NASCIT). Harwood is characterized by its 'active value' approach, often acquiring significant minority or controlling stakes to influence corporate strategy and enhance shareholder value. Its prominent healthcare portfolio includes interests in companies such as Life Science REIT, Tissue Regenix, and SourceBio International, underscoring its role as a key financier and strategic partner in the UK life sciences ecosystem.